1986
DOI: 10.1002/ajh.2830210202
|View full text |Cite
|
Sign up to set email alerts
|

Hemoglobin knossos: A clinical, laboratory, and epidemiological study

Abstract: Hb Knossos is a beta-chain variant (beta 27 Ser----Ala) that is unrecognizable by conventional separation methods but detectable by globin electrophoresis on urea-Triton X-acrylamide gels or by IEF. Hb Knossos is characterized by reduced synthesis and by interaction with beta-thalassemia, in which the double heterozygotes display typical features of thalassemia intermedia. The present paper summarizes the salient genetic, clinical, and biochemical characteristics of five such cases hitherto identified in three… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
4
0
1

Year Published

1987
1987
2014
2014

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 28 publications
1
4
0
1
Order By: Relevance
“…In the TM group a 6-year-old patient from the United Arab Emirates was found to be a compound heterozygous for the Hb Knossos and the NS 39 mutations. This girl was clearly transfusion dependent with a steady state Hb < 5 g/dl indicating that Hb Knossos is not regularly associated with a TI phenotype as suggested previously (Fessas et al, 1986;Baklouti et al, 1986;Altay & Gurgey, 1990;Olds et al, 1991). Similarly, the ¹87 C-G mutation in the b-globin promoter is found in two TM patients.…”
Section: Discussionsupporting
confidence: 68%
“…In the TM group a 6-year-old patient from the United Arab Emirates was found to be a compound heterozygous for the Hb Knossos and the NS 39 mutations. This girl was clearly transfusion dependent with a steady state Hb < 5 g/dl indicating that Hb Knossos is not regularly associated with a TI phenotype as suggested previously (Fessas et al, 1986;Baklouti et al, 1986;Altay & Gurgey, 1990;Olds et al, 1991). Similarly, the ¹87 C-G mutation in the b-globin promoter is found in two TM patients.…”
Section: Discussionsupporting
confidence: 68%
“…In heterozygous state, the mutation results in mild bthalassemia phenotype with a normal HbA2 level, whereas the homozygous state results in intermediate b-thalassemia [9,10]. It's slightly decreased oxygen affinity may account for the observed phenotypes [11].…”
Section: Introductionmentioning
confidence: 99%
“…Thalassemia intermedia may also be caused by hemoglobin variants, alone or on interaction with ␤-thalassemia, which either have reduced synthesis and/or stability [18][19][20][21]. In this latter category altered oxygen binding properties may also play a role in modifying the clinical expression.…”
Section: Discussionmentioning
confidence: 99%